Combination regimen of nirmatrelvir/ritonavir and molnupiravir for the treatment of persistent SARS-CoV-2 infection: A case report and a scoping review of the literature

Immunocompromised patients still experience unpredictable courses of COVID-19, despite that effective vaccines and drugs against SARS-CoV-2 are now available. Antiviral combination regimens may have a role in SARS-CoV-2 infection in immunocompromised hosts, but current knowledge is still limited. We...

Descripción completa

Detalles Bibliográficos
Autores principales: Marangoni, Davide, Antonello, Roberta Maria, Coppi, Marco, Palazzo, Marianna, Nassi, Luca, Streva, Noemi, Povolo, Laura, Malentacchi, Francesca, Zammarchi, Lorenzo, Rossolini, Gian Maria, Vannucchi, Alessandro Maria, Bartoloni, Alessandro, Spinicci, Michele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10198768/
https://www.ncbi.nlm.nih.gov/pubmed/37150351
http://dx.doi.org/10.1016/j.ijid.2023.04.412

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10198768/
https://www.ncbi.nlm.nih.gov/pubmed/37150351
http://dx.doi.org/10.1016/j.ijid.2023.04.412

Ejemplares similares